PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: non-biologic anti-rheumatic drugs
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 6393
- Registration Number
- NCT01646385
A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older
- Conditions
- Pneumococcal VaccinesPneumococcal Conjugate Vaccine
- Interventions
- Biological: 13-valent pneumococcal conjugate vaccineBiological: 23-valent pneumococcal polysaccharide vaccine
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 764
- Registration Number
- NCT01646398
- Locations
- 🇯🇵
Seishinkai Inoue Hospital, Itoshima, Fukuoka, Japan
🇯🇵Yokohama Minoru Clinic, Yokohama, Kanagawa, Japan
🇯🇵Oda Clinic, Shinjuku-ku, Tokyo, Japan
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
- Conditions
- Complicated Urinary Tract InfectionComplicated Intra-abdominal Infection
- Interventions
- First Posted Date
- 2012-07-19
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 345
- Registration Number
- NCT01644643
- Locations
- 🇺🇦
Research Site, Zaporizhzhya, Ukraine
Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years
- Conditions
- Staphylococcal Infections
- Interventions
- Biological: SA4Ag vaccine high doseBiological: PlaceboBiological: SA3Ag vaccineBiological: SA4Ag vaccine low doseBiological: SA4Ag vaccine mid doseProcedure: Blood drawProcedure: Blood sampleProcedure: Colonization swab sampleProcedure: Colonization swab samples
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2019-03-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 284
- Registration Number
- NCT01643941
- Locations
- 🇺🇸
Miami Research Associates, South Miami, Florida, United States
🇺🇸Broward Research Group, Hollywood, Florida, United States
🇺🇸PMG Research of Raleigh, LLC, Cary, North Carolina, United States
Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)
- Conditions
- Rheumatoid Arthritis
- Interventions
- Biological: Rituximab-US + Rituximab-Pfizer x 2 CoursesBiological: Rituximab-Pfizer (PF-05280586) x 3 coursesBiological: Rituximab-EU+ Rituximab-Pfizer x 2 Courses
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 185
- Registration Number
- NCT01643928
- Locations
- 🇨🇴
Clínica Medellín S.A. Sede Centro, Medellín, Antioquia, Colombia
🇨🇴Clinica de La Costa Ltda., Barranquilla, Atlantico, Colombia
🇨🇴IPS Centro Integral De Reumatologia del Caribe, CIRCARIBE S.A.S, Barranquilla, Atlantico, Colombia
A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients
- Conditions
- NSCLC (Non-small Cell Lung Cancer)
- Interventions
- First Posted Date
- 2012-07-12
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 207
- Registration Number
- NCT01639001
- Locations
- 🇨🇳
Chang Gung Medical Foundation, LinKou Branch, Taoyuan, Taiwan
🇨🇳Dept. of Respiration. Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳Hunan Provincial Tumor Hospital/Division of Oncology, Changsha, Hunan, China
A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers
- Conditions
- Healthy
- Interventions
- Biological: PF-04856883
- First Posted Date
- 2012-07-11
- Last Posted Date
- 2015-07-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 49
- Registration Number
- NCT01637285
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
- Conditions
- Healthy
- Interventions
- Drug: bazedoxifene/conjugated estrogens
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2
- Registration Number
- NCT01634789
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin
- Conditions
- Chronic Renal Failure Requiring Hemodialysis
- Interventions
- Biological: Epoetin Hospira
- First Posted Date
- 2012-06-26
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 170
- Registration Number
- NCT01628120
- Locations
- 🇺🇸
Pegasus Dialysis, Bakersfield, California, United States
🇺🇸Azusa Dialysis Center, Azusa, California, United States
🇺🇸Bellflower Dialysis Center, Bellflower, California, United States
A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
- Conditions
- Chronic Renal Failure Requiring Hemodialysis
- Interventions
- Biological: Epoetin Hospira
- First Posted Date
- 2012-06-26
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 406
- Registration Number
- NCT01628107
- Locations
- 🇺🇸
Coconut Creek Dialysis JV, Margate, Florida, United States
🇺🇸American Renal Associates Naples Dialysis Center, Naples, Florida, United States
🇺🇸Tamarac Kidney Center, Tamarac, Florida, United States